CIK 0001861107 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Ceribell, Inc.
Sign in to watch- Ticker
- CBLL
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471785452
- Phone
- (800) 436-0826
- Business address
- 360 N. PASTORIA AVENUE, SUNNYVALE, CA, 94085
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,415,987
- in 16 filings, $3.9M under 10b5-1 plans
Net −$4,415,987. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Chao Xingjuan −$2.5M President and CEO sold 12% of stake
- Blumberg Scott −$938K Chief Financial Officer sold 20% of stake
- Woo Raymond −$417K Chief Technology Officer sold 8% of stake
- Taylor Joseph Michael −$278K Director sold 21% of stake
- Foehr David −$269K Senior VP, Finance and PAO sold 25% of stake
Reading 16 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-05 | Foehr David Senior VP, Finance and PAO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,153 | 63,001 | ||
| 2026-01-05 | Chao Xingjuan President and CEO | Sale 10b5-1 | −54,000 | $21.31 | $1.2M | 741,248 |
| 2026-01-05 | Chao Xingjuan President and CEO | Option exercise 10b5-1 | +1,446 | $4.70 | $7K | 742,694 |
| 2026-01-05 | Chao Xingjuan President and CEO | Sale 10b5-1 | −1,446 | $21.21 | $31K | 741,248 |
| 2026-01-05 | Chao Xingjuan President and CEO | Option exercise 10b5-1 | +23,554 | $4.70 | $111K | 764,802 |
| 2026-01-05 | Chao Xingjuan President and CEO | Sale 10b5-1 | −23,554 | $21.17 | $499K | 741,248 |
| 2026-01-05 | Chao Xingjuan President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,446 | 297,386 | ||
| 2026-01-05 | Chao Xingjuan President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −23,554 | 219,247 | ||
| 2026-01-02 | Woo Raymond Chief Technology Officer | Option exercise 10b5-1 | +1,472 | $2.24 | $3K | 168,789 |
| 2026-01-02 | Woo Raymond Chief Technology Officer | Sale 10b5-1 | −1,472 | $21.29 | $31K | 167,317 |
| 2026-01-02 | Woo Raymond Chief Technology Officer | Option exercise 10b5-1 | +3,025 | $4.70 | $14K | 170,342 |
| 2026-01-02 | Woo Raymond Chief Technology Officer | Sale 10b5-1 | −3,025 | $21.18 | $64K | 167,317 |
| 2026-01-02 | Woo Raymond Chief Technology Officer | Option exercise 10b5-1 | +6,615 | $4.70 | $31K | 173,932 |
| 2026-01-02 | Woo Raymond Chief Technology Officer | Sale 10b5-1 | −6,615 | $21.16 | $140K | 167,317 |
| 2026-01-02 | Woo Raymond Chief Technology Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,472 | 14,274 | ||
| 2026-01-02 | Woo Raymond Chief Technology Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,025 | 44,796 | ||
| 2026-01-02 | Woo Raymond Chief Technology Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,615 | 45,523 | ||
| 2026-01-02 | ROBERTSON REBECCA B Director | Option exercise 10b5-1 | +2,500 | $2.24 | $6K | 22,076 |
| 2026-01-02 | ROBERTSON REBECCA B Director | Sale 10b5-1 | −2,500 | $21.89 | $55K | 19,576 |
| 2026-01-02 | ROBERTSON REBECCA B Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,500 | 7,650 |
Page 11 of 17 · 330 trades